ELMSFORD, N.Y.--(BUSINESS WIRE)--March 2, 2006--BioScrip, Inc. (NASDAQ: BIOS) today announced that it has acquired Intravenous Therapy Services (“ITS”), a specialty infusion company located in Burbank, California. In addition, the Company announced that it has increased its existing revolving credit facility with HFG Healthco-4 LLC, the Company’s primary lender, to $65 million.